The major substrates for TAP in vivo are derived from newly synthesized proteins

被引:325
作者
Reits, EAJ [1 ]
Vos, JC [1 ]
Grommé, M [1 ]
Neefjes, J [1 ]
机构
[1] Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands
关键词
D O I
10.1038/35008103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transporter associated with antigen processing (TAP) is a member of the family of ABC transporters that translocate a large variety of substrates across membranes(1). TAP transports peptides from the cytosol into the endoplasmic reticulum for binding to MHC class I molecules and for subsequent presentation to the immune system(2). Here we follow the lateral mobility of TAP in living cells. TAP's mobility increases when it is inactive and decreases when it translocates peptides. Because TAP activity is dependent on substrate, the mobility of TAP is used to monitor the intracellular peptide content in vivo. Comparison of the diffusion rates in peptide-free and peptide-saturated cells indicates that normally about one-third of all TAP molecules actively translocate peptides. However, during an acute influenza infection TAP becomes fully employed owing to the production and degradation of viral proteins. Furthermore, TAP activity depends on continuing protein translation. This implies that MHC class I molecules mainly sample peptides that originate from newly synthesized proteins, to ensure rapid presentation to the immune system.
引用
收藏
页码:774 / 778
页数:6
相关论文
共 29 条
[1]   The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP [J].
Ahn, K ;
Gruhler, A ;
Galocha, B ;
Jones, TR ;
Wiertz, EJHJ ;
Ploegh, HL ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
IMMUNITY, 1997, 6 (05) :613-621
[2]   MOBILITY MEASUREMENT BY ANALYSIS OF FLUORESCENCE PHOTOBLEACHING RECOVERY KINETICS [J].
AXELROD, D ;
KOPPEL, DE ;
SCHLESSINGER, J ;
ELSON, E ;
WEBB, WW .
BIOPHYSICAL JOURNAL, 1976, 16 (09) :1055-1069
[3]   Atomic scale movement of the voltage-sensing region in a potassium channel measured via spectroscopy [J].
Cha, A ;
Snyder, GE ;
Selvin, PR ;
Bezanilla, F .
NATURE, 1999, 402 (6763) :809-813
[4]  
DELEIJ L, 1985, CANCER RES, V45, P6024
[5]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[6]   The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics [J].
Gromme, M ;
vanderValk, R ;
Sliedregt, K ;
Vernie, L ;
Liskamp, R ;
Hammerling, G ;
Koopmann, JO ;
Momburg, F ;
Neefjes, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :898-904
[7]   Recycling MHC class I molecules and endosomal peptide loading [J].
Grommé, M ;
Uytdehaag, FGCM ;
Janssen, H ;
Calafat, J ;
van Binnendijk, RS ;
Kenter, MJH ;
Tulp, A ;
Verwoerd, D ;
Neefjes, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10326-10331
[8]   ANTIINFLUENZA VIRUS ACTIVITY OF THE COMPOUND LY253963 [J].
HAYDEN, FG ;
ROLLINS, BS ;
HAY, AJ .
ANTIVIRAL RESEARCH, 1990, 14 (01) :25-38
[9]   A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter [J].
Hengel, H ;
Koopmann, JO ;
Flohr, T ;
Muranyi, W ;
Goulmy, E ;
Hammerling, GJ ;
Koszinowski, UH ;
Momburg, F .
IMMUNITY, 1997, 6 (05) :623-632
[10]   ABC TRANSPORTERS - FROM MICROORGANISMS TO MAN [J].
HIGGINS, CF .
ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :67-113